Cardiac Pump Equipment Market: Revenue Growth, Key Players, Qualitative Analysis, Quantitative Analysis, Forecast up to 2030

SDKI Inc. published a new research report on "Cardiac Pumping Equipment Market-Global Forecast 2022". The report provides a complete assessment of the market and its growth prospects, along with new business opportunities in the industry. It also includes market size and annual growth during the 2017-2022 forecast period.

Report sample URL
https://www.sdki.jp/sample-request-109760

The global cardiac pump device market is estimated to reach US $ 3.98 billion by 2022 from US $ 1.64 billion in 2017 and is expected to grow at a CAGR of 19.4% during the forecast period. Increased prevalence of cardiovascular disease, increased regulatory approvals, and a large gap in supply and demand for donor hearts are driving demand for cardiac pumping devices. Also, due to the shortage of heart donors, heart pumping devices serve as an ideal alternative, further driving the growth of the global market. In addition, the increased morbidity and mortality of heart failure in developed countries is expected to provide growth opportunities for cardiac pump device manufacturers.

However, preference for alternative drug delivery modes and inadequate redemption scenarios in developing countries is expected to curb growth in this market during the forecast period.

Report sample URL
https://www.sdki.jp/sample-request-109760

Market segment

The heart pump device market is by product (ventricular assist device (LVAD, RVAD, BiVAD, and pVAD), intra-aortic balloon pump, TAH), type (extracorporeal and implantable pump), treatment (bridge to transplant, Destination treatment) and divided by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Based on the product, the ventricular assist device segment is expected to grow at a maximum CAGR during the forecast period (2017-2022).

Based on the product, the market is divided into ventricular assist devices, intra-aortic balloon pumps, and complete artificial hearts. The ventricular assist device segment is expected to grow at a maximum CAGR during the forecast period. This growth may be due to the increased safety and effectiveness of these devices as a result of technological advances.

Based on treatment, the destination treatment segment is expected to grow at a significant CAGR during the forecast period.

Based on treatment, the global cardiac pumping device market is divided into bridge-to-transplant, bridge-to-candidate, destination therapies, and other therapies such as bridge-to-recovery and rescue therapies. The destination treatment segment is expected to grow at a significant CAGR during the forecast period.

Regional Overview

In addition, the report covers all regions of the world, divided into North America, Europe, Asia Pacific, Latin America, Middle East & Africa and more. The North American region is expected to achieve the highest growth between 2017 and 2022. The highest growth rates in the region's market are due to increased prevalence of cardiovascular disease, favorable reimbursement scenarios, and increased regulatory approvals in the region.

For more detailed analysis, each region is further divided into countries:
Asia Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, and other Asia Pacific)
North America (US and Canada)
Middle East and Africa (Israel, GCC [Saudi Arabia, United Arab Emirates, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, and other Middle East and Africa)
Latin America (Brazil, Mexico, Argentina, and other Latin America)
Europe (UK, Germany, France, Italy, Spain, Hungary, Belgium, Netherlands, Luxemburg, NORDIC, Poland, Turkey, Russia and other Europe).

Details of the survey report
https://www.sdki.jp/reports/heart-pump-device-market/109760

Key Players:

In the cardiac pumping device market are St. Jude Medical (subsidiary of Abbott Laboratories) (USA), Abiomed (USA), Medtronic (Ireland), Gettinge (Sweden), Teleflex (USA). ), ReliantHeart (USA), BerlinHeart (Germany), Terumo (Japan), SynCardia Systems (USA), TandemLife (CardiacAssist) (USA), Jarvik Heart (USA), Fresenius Medical Care (Germany). The study includes a detailed competitive analysis of these major companies in the cardiac pumping equipment market, corporate profiles, recent developments, and key market strategies.

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.